共 23 条
[1]
Scott LM(2005)The V617F JAK2 mutation is uncommon in cancers and in myeloid malignancies other than the classic myeloproliferative disorders Blood 106 2920-1
[2]
Campbell PJ(2007)JAK2–V617F mutation in a patient with Philadelphia-chromosome-positive chronic myeloid leukaemia Lancet Oncol 8 658-60
[3]
Baxter EJ(2007)Myelofibrosis evolving during imatinib treatment of a chronic myeloproliferative disease with coexisting BCR-ABL translocation and JAK2V617F mutation Blood 109 4106-7
[4]
Kramer A(2005)Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders Lancet 365 1054-61
[5]
Reiter A(2007)Concurrent JAK2 (V617F) mutation and BCR-ABL translocation within committed myeloid progenitors in myelofibrosis Leukemia 21 1824-6
[6]
Kruth J(2007)Insights into JAK2–V617F mutation in CML Lancet Oncol 8 863-4
[7]
Hussein K(2007)Insights into JAK2–V617F mutation in CML Lancet Oncol 8 864-6
[8]
Bock O(undefined)undefined undefined undefined undefined-undefined
[9]
Seegers A(undefined)undefined undefined undefined undefined-undefined
[10]
Flasshove M(undefined)undefined undefined undefined undefined-undefined